SEC Form 4 · accession 0001104659-18-057814

Principia Biopharma Inc. · PRNB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Sep 18, 2018

Accepted (ET)

Sep 20, 2018 · 4:14 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001510487

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Sep 18, 2018	C	208,480	—	A	208,480	I	See footnote
Common Stock^F2	Sep 18, 2018	P	175,000	$17.00	A	383,480	I	See footnote

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Series C Preferred Stock^F1,F2	—	Sep 18, 2018	C	208,480	D	—	—	Common Stock	208,480	0	I

F1Each share of Series C Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis, for no additional consideration, upon the closing of the Issuer's initial public offering. The Series C Preferred Stock had no expiration date.
F2Shares are held by Samsara BioCapital, L.P. ("Samsara BioCapital"). The reporting person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara BioCapital. The Reporting Person disclaims beneficial ownership of these shares except to the extent of the Reporting Person's pecuniary interest therein.